Does Medicare Cover Invitae Genetic Testing Costs for SSDI Recipients?

If you're on SSDI and your doctor has ordered genetic testing through a lab like Invitae, you're probably wondering whether Medicare will pick up the tab. The answer isn't a flat yes or no — it sits in the middle of several overlapping rules about Medicare coverage, medical necessity, and how genetic testing fits into the broader landscape of what Part B and Part D actually pay for.

Here's what you need to understand about how this works.

What Is Invitae and Why Does It Come Up for SSDI Recipients?

Invitae is a genetic testing company that offers panels for inherited conditions — hereditary cancers, cardiac disorders, neurological conditions, and more. For people with disabilities, genetic testing can play a role in confirming a diagnosis, guiding treatment, or identifying hereditary risks that affect ongoing care.

SSDI recipients become eligible for Medicare after a 24-month waiting period from their established disability onset date. Once enrolled, Medicare becomes their primary health coverage — and whether Invitae testing gets covered falls under Medicare's standard rules for diagnostic lab services.

How Medicare Approaches Genetic Testing Coverage

Medicare does cover genetic testing — but only under specific conditions. The governing framework is medical necessity, and it applies to both Part B (outpatient/diagnostic services) and sometimes Part A (inpatient).

The core rule: Medicare covers a diagnostic test when it is ordered by a treating physician, is reasonable and necessary for the diagnosis or treatment of an illness or injury, and meets the criteria in a Local Coverage Determination (LCD) or National Coverage Determination (NCD).

For genetic testing, this is where things get complicated. The Centers for Medicare & Medicaid Services (CMS) has issued specific coverage policies for certain genetic tests — including some germline and somatic tumor profiling tests — but coverage is not blanket. Each test type has its own set of criteria.

Local Coverage Determinations: The Hidden Variable 🔍

Much of genetic testing coverage is governed by LCDs issued by Medicare Administrative Contractors (MACs). These are regional rules, which means coverage can differ depending on which MAC administers claims in your geographic area.

For a test like an Invitae panel, the MAC in your region may have an LCD that:

• Covers the test for specific diagnoses (e.g., hereditary breast and ovarian cancer syndrome, Lynch syndrome, hypertrophic cardiomyopathy)
• Requires specific ICD-10 diagnosis codes on the ordering physician's documentation
• Mandates that the test be ordered by a specialist in certain cases
• Requires prior authorization or additional documentation

If your physician's order and your diagnosis align with the applicable LCD criteria, Medicare will typically cover the test at the standard Part B cost-sharing rate — meaning 80% after the deductible, with you responsible for the remaining 20% unless you have supplemental coverage.

If your situation falls outside those criteria, Medicare may deny the claim as not medically necessary.

What Invitae's Own Billing Practices Add to the Picture

Invitae has historically offered financial assistance programs and sometimes billed insurers directly, with reduced patient cost-sharing. However, the lab's billing and assistance policies are separate from what Medicare decides to cover. If Medicare denies a claim, any patient responsibility depends on:

• Whether Invitae is a participating Medicare provider
• Whether an Advance Beneficiary Notice of Noncoverage (ABN) was issued before the test
• Whether Invitae's own assistance programs apply to Medicare patients

An ABN is a written notice a lab or provider gives you before a service Medicare may not cover. If you sign an ABN, you're acknowledging you may owe the full cost out of pocket. If no ABN was provided and Medicare denies the claim, your financial liability may be limited — but this plays out case by case.

How Coverage Varies Across Different Claimant Profiles

Dual eligibility — receiving both Medicare and Medicaid — is common among SSDI recipients with low income. In those cases, Medicaid often acts as a secondary payer and may cover services Medicare denies, depending on the state's Medicaid program rules.

The Medical Necessity Documentation Chain

Whether Medicare pays for Invitae testing often comes down to paperwork. ⚕️ The ordering physician needs to document:

• A clear clinical indication tied to a covered diagnosis code
• Why genetic testing is necessary for treatment decisions (not just curiosity or family history alone, in most cases)
• That the test ordered matches what the LCD requires

When documentation is incomplete or misaligned with LCD criteria, claims get denied even when the underlying medical need is real. Denials can be appealed — through Medicare's standard appeals process (redetermination → reconsideration → ALJ hearing → Appeals Council → federal court) — though the process takes time and requires supporting clinical documentation.

The Part Your Own Situation Determines

Whether Medicare covers your specific Invitae test depends on your diagnosis, the precise panel your physician ordered, the LCD in your region, your dual eligibility status, and how your physician documented the order. Two SSDI recipients with similar conditions can receive different coverage decisions based on differences in how the claim was submitted, which MAC processed it, and whether supplemental coverage filled the gap.

The program rules create a framework. What happens inside that framework is shaped entirely by the details of your case — and those details are yours alone to sort through with your physician and Medicare directly.